Phathom Pharmaceuticals, Inc.
Phathom Pharmaceuticals, Inc.（PHAT）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · PHAT · 截至 2026年6月9日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
3
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Phathom Pharmaceuticals, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
PHAT 季度内部人买卖趋势
PHAT 内幕交易卖出 · PHAT 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
活跃内部人
近12个月交易最活跃 · PHAT CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
PHAT 高管卖出股份 · PHAT 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| May 22, 2026 | Parikh Asit Director | Gift | 28,000 | — | Form 4 |
| May 22, 2026 | Parikh Asit Director | Gift | 28,000 | — | Form 4 |
| May 20, 2026 | Parikh Asit Director | Option | 17,500 | $87K | Form 4 |
| May 19, 2026 | Parikh Asit Director | Award | 24,122 | — | Form 4 |
| May 19, 2026 | Topper James N Director | Award | 24,122 | — | Form 4 |
| May 19, 2026 | Stenhouse Mark Director | Award | 24,122 | — | Form 4 |
| May 19, 2026 | FIELDS HEIDI Director | Award | 24,122 | — | Form 4 |
| May 19, 2026 | COLA MICHAEL F Director | Award | 24,122 | — | Form 4 |
| May 19, 2026 | KARBE FRANK Director | Award | 24,122 | — | Form 4 |
| May 19, 2026 | Schroeder Theodore R Director | Award | 24,122 | — | Form 4 |
| Mar 10, 2026 | Parikh Asit Director | Gift | 40,000 | — | Form 4 |
| Mar 10, 2026 | Parikh Asit Director | Gift | 40,000 | — | Form 4 |
| Feb 27, 2026 | Breedlove Robert Charles PAO | Award | 2,790 | — | Form 4 |
| Feb 27, 2026 | Breedlove Robert Charles PAO | Other | 964 | $12K | Form 4 |
| Feb 27, 2026 | Breedlove Robert Charles PAO | Other | 414 | $5K | Form 4 |
| Feb 27, 2026 | Breedlove Robert Charles PAO | Award | 13,000 | — | Form 4 |
| Feb 10, 2026 | Cook Anne Marie Chief Legal Off. & Corp. Sec. | Award | 3,461 | — | Form 4 |
| Feb 10, 2026 | Cook Anne Marie Chief Legal Off. & Corp. Sec. | Other | 1,535 | $20K | Form 4 |
| Feb 10, 2026 | Basta Steven L President and CEO · Director | Award | 12,362 | — | Form 4 |
| Feb 10, 2026 | Basta Steven L President and CEO · Director | Other | 6,277 | $80K | Form 4 |
| Jan 23, 2026 | Parikh Asit Director | Gift | 80,500 | — | Form 4 |
| Jan 23, 2026 | Parikh Asit Director | Gift | 80,500 | — | Form 4 |
| Jan 21, 2026 | Breedlove Robert Charles PAO | Other | 776 | $11K | Form 4 |
| Jan 13, 2026 | Parikh Asit Director | Option | 8,750 | $90K | Form 4 |
| Jan 2, 2026 | Basta Steven L President and CEO · Director | Award | 251,034 | — | Form 4 |
Cook Anne Marie
Chief Legal Off. & Corp. Sec.
日期
Feb 10
股数
1,535
均价
$12.82
总金额
$20K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 PHAT 内幕交易
PHAT 内幕交易
Phathom Pharmaceuticals, Inc.（PHAT）内幕交易数据来源于公司内部人（包括Parikh Asit (Director), Breedlove Robert Charles (PAO), Basta Steven L (President and CEO · Director)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。PHAT内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Phathom Pharmaceuticals, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
PHAT 内幕交易 · 5个问题Phathom Pharmaceuticals, Inc.（PHAT）的内部人包括高管和董事，如Parikh Asit (Director), Breedlove Robert Charles (PAO), Basta Steven L (President and CEO · Director)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026